Commodities 44206-0417-06 6GM globuline, immune carimune 44206-0436-05 5GM globuline, immune privigen 44206-0418-12 12GM globuline, immune carimune

Ended Awarded

Contract number
VA24817J3324
Awardee
Awarding agency
Obligated
$77,626

Award facts

Contract value 100% obligated
$77,625.80 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
King of Prussia, PA 19406, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a global biotherapeutics company specializing in plasma-derived and recombinant therapies. The contract, valued at $77,625.80, is a Blanket Purchase Agreement (BPA) call under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a ceiling value of $201,482,280 and is valid through September 2026. The awarded BPA call is for the delivery of specific pharmaceutical products, including CARIMUNE (6 gm and 12 gm immune globulin) and PRIVIGEN (5 gm immune globulin), to VA medical facilities. This contract does not have a set-aside designation, reflecting CSL Behring's status as a large, foreign-owned enterprise. The contract supports the VA's efforts to provide critical medical treatments and specialty pharmaceuticals to veterans through its integrated service networks.

Quick answers

Who was awarded contract VA24817J3324?

VA24817J3324 was awarded to CSL Behring L.L.C. by Veterans Integrated Service Network 8 (Veterans Health Administration) on May 26, 2017.

How much is contract VA24817J3324 worth?

The government has obligated $77,626 on VA24817J3324.

Is contract VA24817J3324 an order under another contract?

Yes. VA24817J3324 is a BPA call under V797D50358-VA24816A0004, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract VA24817J3324 competed?

The extent of competition for VA24817J3324 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award